Spiderwort Inc. is at the forefront of regenerative medicine, focusing on the development of innovative plant-based biomaterials designed to facilitate the repair and regeneration of living tissues. The company utilizes proprietary cellulose-based biomaterials to create scaffolds that are applicable in various groundbreaking regenerative medicine applications. Their research includes promising advancements in biotechnology, particularly in the areas of dermal fillers and medical devices for spinal cord injuries, showcasing the potential of these materials in enhancing medical treatments and aesthetic procedures.

Among Spiderwort's key products are CelluBridge and CelluJuve, both of which leverage cellulose-based technology. CelluBridge is being developed as a scaffold to support spinal cord repair and regeneration, while CelluJuve is a dermal filler aimed at facial tissue augmentation and rejuvenation. These products exemplify Spiderwort's commitment to advancing regenerative medicine and tissue engineering, offering significant potential for improving patient outcomes in both medical and aesthetic contexts.

Canada

Spiderwortisdeveloping a novel biomaterial that will offer new avenues in 3D in vitro research and in regenerative medicineusing plant derived cellulose to create a variety of scaffold architectures.

Spiderwort

Company Details